PMID- 28627185 OWN - NLM STAT- MEDLINE DCOM- 20180521 LR - 20181023 IS - 1699-5198 (Electronic) IS - 0212-1611 (Linking) VI - 34 IP - 3 DP - 2017 Jun 5 TI - [Adherence and tolerance as key in brake on weight loss in cancer patients with nutritional risk after intervention with a high calorie nutritional and specific hyperproteic supplement]. PG - 524-531 LID - 10.20960/nh.1331 [doi] AB - Background: In patients with nutritional risk, the European Society for Clinical Nutrition and Metabolism (ESPEN) recommends nutritional supplements during cancer treatment to prevent weight loss. Objectives: Our goal is to determine the acceptability, compliance and tolerance of a hyperproteic, high-calorie, omega-3 enriched supplement in cancer patients. Methods: Unicentric, prospective observational study in cancer patients with hyperproteic, high-calorie, rich in omega 3 and low volume nutritional supplement. Thirty patients with malnutrition or risk of malnutrition were included. Supplementation lasted six days. Compliance (packaging used), acceptability (Madrid scale), anthropometric variables and gastrointestinal adverse events (AEs) were evaluated. Results: Seventy per cent were men, with an average age of 60 years (range 32-79), with lung (43.3%), ENT (26.7%) and breast neoplasms (13.3%), stage III-IV (56.7%), and treated with radiotherapy (93.3%), chemotherapy (60%) and surgery (16.7%). The product was accepted by all patients. A compliance rate of 100% was observed. Gastrointestinal AE (grade II) related to the supplement was observed in two patients (6.7%). Both subjects had previous gastrointestinal diseases. The median weight, body mass index (BMI) and protein intake increased during supplementation (0.2 kg, 0.1 kg/m2 and 6.2 g). No differences were observed regarding calorie, fat and carbohydrates intake. Conclusion: The high acceptance and compliance with the specific nutritional supplement was associated with an improved nutritional status for cancer patients, and reversed the weight loss without severe gastrointestinal problems, or producing intake displacement. FAU - Garcia Almeida, Jose M AU - Garcia Almeida JM AD - . jgarciaalmeida@gmail.com. FAU - Lupianez Perez, Yolanda AU - Lupianez Perez Y FAU - Blanco Naveira, Mercedes AU - Blanco Naveira M FAU - Ruiz Nava, Josefina AU - Ruiz Nava J FAU - Medina, Jose Antonio AU - Medina JA FAU - Cornejo Pareja, Isabel AU - Cornejo Pareja I FAU - Gomez Perez, Ana AU - Gomez Perez A FAU - Molina Vega, Maria AU - Molina Vega M FAU - Lopez-Medina, Jose A AU - Lopez-Medina JA FAU - Tinahones Madueno, Francisco AU - Tinahones Madueno F LA - spa PT - Journal Article PT - Observational Study TT - Adherencia y tolerancia como claves en la detencion de la perdida de peso en pacientes oncologicos sometidos a radioterapia mediante una estrategia de suplementacion precoz con una formula enteral hipercalorica e hiperproteica especifica. DEP - 20170605 PL - Spain TA - Nutr Hosp JT - Nutricion hospitalaria JID - 9100365 RN - 0 (Dietary Proteins) RN - 0 (Fatty Acids, Omega-3) SB - IM MH - Adult MH - Aged MH - Dietary Proteins/*therapeutic use MH - *Dietary Supplements MH - Energy Intake MH - Fatty Acids, Omega-3/therapeutic use MH - Female MH - Humans MH - Male MH - Middle Aged MH - Neoplasms/*complications/therapy MH - Nutrition Disorders/*etiology/*therapy MH - Nutrition Therapy MH - Nutritional Status MH - Patient Acceptance of Health Care MH - Prospective Studies MH - Risk MH - *Weight Loss OTO - NOTNLM OT - Desnutricion relacionada con la enfermedad aguda. Suplemento nutricional. Oncologia. Acidos grasos omega 3. Nutricion oral. EDAT- 2017/06/20 06:00 MHDA- 2018/05/22 06:00 CRDT- 2017/06/20 06:00 PHST- 2017/06/05 00:00 [received] PHST- 2017/06/20 06:00 [entrez] PHST- 2017/06/20 06:00 [pubmed] PHST- 2018/05/22 06:00 [medline] AID - 10.20960/nh.1331 [doi] PST - epublish SO - Nutr Hosp. 2017 Jun 5;34(3):524-531. doi: 10.20960/nh.1331.